Ximenes Guilherme, Saha Sajal K, Guterres Helio, Vieira Adriano, Harris Lisa, Mahony Michelle, Dos Santos Agata, Toto Lucia, Amaral Elfiana, Spargo Jessie C, Tay Sze Yen, Amaral Salvador, Champlin Karen, Draper Anthony D K, Francis Joshua R, Yan Jennifer, Lynar Sarah A
Menzies School of Health Research, Charles Darwin University, Dili, Timor-Leste.
Pharmacy Department, Hospital Nacional Guido Valadares, Dili, Timor-Leste.
JAC Antimicrob Resist. 2024 Aug 1;6(4):dlae123. doi: 10.1093/jacamr/dlae123. eCollection 2024 Aug.
To describe antimicrobial use (AMU) in patients admitted to hospitals in Timor-Leste.
In 2020 and 2021, we undertook antimicrobial prescribing point prevalence surveys across all six hospitals in Timor-Leste (one national and five municipal) to describe AMU and appropriateness in admitted patients.
In 2020, 291/394 (73.9%) surveyed patients had been prescribed antimicrobials, compared with 260/403 (64.5%) in 2021 ( = 0.004). Most (309/551; 56.1%) were prescribed one antimicrobial, and 179/551 (32.5%) were prescribed two. The most commonly prescribed antibiotics were ceftriaxone (38.5% in 2020, 41.5% in 2021) and ampicillin (35.7% in 2020, 32.3% in 2021), followed by gentamicin, metronidazole and cloxacillin. Reserve antibiotics like meropenem and vancomycin were minimally used. Of all antimicrobial prescriptions, 70.8% were deemed appropriate in 2020 and 69.1% in 2021. Antimicrobial prescriptions for surgical and post-partum prophylaxis were frequently deemed inappropriate [37/50 (74.0%) and 39/44 (88.6%) prescriptions, respectively].
Most patients admitted to hospital in Timor-Leste are prescribed antimicrobials, and approximately one-third of these prescriptions are inappropriate. However, this was in the context of limited local guideline availability at the time of surveys and limited microbiological culture capacity outside of the capital, Dili. Improved microbiological guidance, iterative guideline revisions based on local antimicrobial resistance (AMR) surveillance data, and enhanced stewardship activities including further point prevalence studies, could improve antimicrobial use, optimize patient outcomes and reduce AMR in Timor-Leste.
描述东帝汶住院患者的抗菌药物使用情况。
在2020年和2021年,我们对东帝汶所有六家医院(一家国家级医院和五家市级医院)进行了抗菌药物处方现患率调查,以描述住院患者的抗菌药物使用情况及合理性。
2020年,394名接受调查的患者中有291名(73.9%)接受了抗菌药物处方,2021年这一比例为260/403(64.5%)(P = 0.004)。大多数(309/551;56.1%)患者接受了一种抗菌药物处方,179/551(32.5%)患者接受了两种抗菌药物处方。最常开具的抗生素是头孢曲松(2020年为38.5%,2021年为41.5%)和氨苄西林(2020年为35.7%,2021年为32.3%),其次是庆大霉素、甲硝唑和氯唑西林。美罗培南和万古霉素等储备抗生素使用极少。在所有抗菌药物处方中,2020年70.8%被认为是合理的,2021年为69.1%。外科手术和产后预防的抗菌药物处方经常被认为不合理[分别为37/50(74.0%)和39/44(88.6%)的处方]。
东帝汶大多数住院患者都接受了抗菌药物处方,其中约三分之一的处方不合理。然而,这是在调查时当地指南有限且首都帝力以外地区微生物培养能力有限的背景下出现的情况。改进微生物学指导、根据当地抗菌药物耐药性监测数据进行迭代指南修订以及加强管理活动,包括进一步的现患率研究,可能会改善东帝汶抗菌药物的使用情况,优化患者治疗效果并降低抗菌药物耐药性。